English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe 2022 Panjiayuan Consensus Conference, held by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, has introduced pivotal advancements in prostate targeted biopsy (TB) strategies and development, marking a significant leap forward in the diagnosis and management of prostate cancer (PCa).
Tag: Biopsy
Invenio Imaging Announces First Patients Enrolled in US Pivotal Study of AI-Based Image Analysis Module for Lung Cancer
Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today the enrollment of the first patients in a US pivotal study of its AI-based image analysis module for lung cancer.
Important update re Annals Embargoed Tip Sheet for 4/30
The article referenced in this tip on color ultrasound for suspected GCA will not be published on April 30. ͏
Case Western Reserve University-led research team discovers new method to test for oral cancer
A team of researchers, led by a clinician scientist at the Case Western Reserve University School of Dental Medicine, has discovered a noninvasive, low-cost test to detect oral cancer, monitor precancerous lesions and determine when a biopsy is warranted.
BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use
Dr. Palmer brings significant expertise both as a clinical oncologist and as a high-level executive at several national laboratories. His prior industry roles include CMO at Tempus Labs, VP of Medical Affairs at Foundation Medicine, and VP of Medical Affairs at Genomic Health.
AI can be used to identify benign thyroid nodules and reduce unnecessary biopsies
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
6 skin biopsy wound care tips from dermatologists
Skin cancer is the most common form of cancer. It is estimated that one in five Americans will develop skin cancer in their lifetime. As Skin Cancer Awareness Month continues, it’s important to check your skin regularly, and if you notice a spot on your skin that is different from others or that changes, itches, or bleeds, make an appointment to see a board-certified dermatologist.
First in the World! Chulalongkorn Hospital Successfully Treats a Breast Cancer Patient with Immunotherapy
Queen Sirikit Center for Breast Cancer, King Chulalongkorn Memorial Hospital, Thai Red Cross Society (Chulalongkorn Hospital) has become the world’s first institution to have successfully used immunotherapy to treat a breast cancer patient who is now in complete remission with minimal side effects and uplifted quality of life.
‘Vanished’ or ‘hidden’ prostate cancer? Men with negative biopsies during active surveillance have good outcomes
Can early-stage prostate cancer “vanish” during follow-up? More likely the cancer is just “hidden”—either way, negative biopsies during active surveillance for prostate cancer are associated with excellent long-term outcomes, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Personalized drug screens could guide treatment for children with brain cancer
Scientists at Sanford Burnham Prebys Medical Discovery Institute, University of California San Diego School of Medicine and Hopp Children’s Cancer Center Heidelberg (KiTZ) have demonstrated that personalized drug screens can be used to identify new therapeutic candidates for medulloblastoma. The approach measures the effectiveness of therapeutics using tumor cells obtained from a biopsy and can be performed in a few days—making it one of the quickest sources of information used in clinical decision-making.
Low risk of cancer spread on active surveillance for early prostate cancer
Men undergoing active surveillance for prostate cancer have very low rates – one percent or less – of cancer spread (metastases) or death from prostate cancer, according to a recent study published in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Houston Methodist using 3D technology, artificial intelligence and more in new breast cancer research studies
Trials include a model to create custom breast implants, a smarter method to recommend biopsy, a novel approach to preserve sensation in implant-based breast reconstruction, and a new clinical trial investigating a modified herpes virus as a tactic to trigger immune response.
Freezing prostate cancer: Study shows notable outcomes with cryoablation
A less-invasive treatment technique called hemi-gland cryoablation (HGCryo) – destroying the areas of the prostate where cancers are located by freezing them – provides a high rate of effective prostate cancer control, according to a new study published in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Hackensack University Medical Center Becomes First in New Jersey to Perform Revolutionary Minimally Invasive Robotic Lung Biopsy Procedure
More than 70% of lung nodules that need to be biopsied (analyzed to see if they are cancer) reside far out in the periphery of the lung, making them very difficult to biopsy using conventional bronchoscopy (a tube with a camera on its tip inserted through a patient’s mouth into the lungs). The Ion system combines computed tomography (CT) data and robotic-assisted surgical technology to facilitate and expedite access to these nodules. The entire procedure is performed through bronchoscopy, without the need for any external surgical incisions.